Comorbidity and persistence of disease-modifying therapy use in relapsing remitting multiple sclerosis

John D. Fisk

doi:10.1016/j.msard.2021.103249

Comorbidity and persistence of disease-modifying therapy use in relapsing remitting multiple sclerosis

John D. Fisk

Neuroscience

科研成果: 期刊稿件 › 文章 › 同行评审

7 引用（Scopus）

源语言	英语
文章编号	103249
期刊	Multiple Sclerosis and Related Disorders
卷	56
DOI	https://doi.org/10.1016/j.msard.2021.103249
出版状态	已出版 - 11月 2021

!!!ASJC Scopus Subject Areas

临床神经病学
神经病学

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1016/j.msard.2021.103249

其它文件与链接

引用此

@article{a898ae0c02da42b6bd6e7eed8166f7d0,

title = "Comorbidity and persistence of disease-modifying therapy use in relapsing remitting multiple sclerosis",

keywords = "Comorbidity, Disease-modifying therapy, Medication persistence, Multiple sclerosis",

author = "Fisk, {John D.}",

note = "Publisher Copyright: {\textcopyright} 2021 Elsevier B.V.",

year = "2021",

month = nov,

doi = "10.1016/j.msard.2021.103249",

language = "English",

volume = "56",

journal = "Multiple Sclerosis and Related Disorders",

issn = "2211-0348",

publisher = "Elsevier",

}

TY - JOUR

T1 - Comorbidity and persistence of disease-modifying therapy use in relapsing remitting multiple sclerosis

AU - Fisk, John D.

PY - 2021/11

Y1 - 2021/11

KW - Comorbidity

KW - Disease-modifying therapy

KW - Medication persistence

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=85114697951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85114697951&partnerID=8YFLogxK

U2 - 10.1016/j.msard.2021.103249

DO - 10.1016/j.msard.2021.103249

M3 - Article

C2 - 34517192

AN - SCOPUS:85114697951

SN - 2211-0348

VL - 56

JO - Multiple Sclerosis and Related Disorders

JF - Multiple Sclerosis and Related Disorders

M1 - 103249

ER -

Comorbidity and persistence of disease-modifying therapy use in relapsing remitting multiple sclerosis

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此